Durvalumab Long-Term Safety and Efficacy Study

NCT04078152 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

163

Enrollment

INDUSTRY

Sponsor class

Conditions

Solid Tumor

Interventions

DRUG: Durvalumab

Sponsor

AstraZeneca

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]